Need Consent-Ready Patients Fast?

Hit the ground running with strong recruitment

See how Medtack helps sponsors recruit trials faster:

• Identify high potential sites for advertising

• Turn them into Super-Enrollers

• Optimize the journey to consent

Is your recruitment off track? Need a rescue?

You are under pressure, and you need to turn things around fast. See how Medtack generates robust pipelines of consent-ready patients fast.

How does Medtack recruit patients faster?

A pivotal trial for on implantable device increased monthly recruitment 7x in just 3 months using Medtack.

Medtack leverages the power of technology

Medtack deploys cutting-edge technology to streamline the traditional journey to patient-consent, making it more cost effective, faster, and a smoother exeperience for everyone.

Credent Partners named e-clinical trial company of the year

– Pharma Tech Outlook (click to read article)

They have developed an innovative and cost-effective platform to recruit clinical trials faster.

Nadim Yared
ex-CEO, CVRx Inc.

“Their comprehensive clinical trial recruitment system works smoothly and the quality of their marketing is exceptional.

Todd Langevin
President Biotronik Neuro

“Once we switched to Medtack, patient recruitment took off like a rocket!

Idan Geva
CEO Butterfly Medical

.

They have developed an innovative and cost-effective platform to recruit clinical trials faster.

Nadim Yared
ex-CEO, CVRx Inc.

.

“Their comprehensive clinical trial recruitment works smoothly and the quality of their marketing is exceptional.

Todd Langevin
President Biotronik Neuro

.

“Once we switched to Medtack, patient recruitment took off like a rocket!

Idan Geva
CEO Butterfly Medical

Test the power of Medtack with  no-fees

Step 1

Schedule a Capabilities Presentation with our Chief Strategy Officer.

Step 2

Get a Free Clinical Trial Recruitment Plan including a detailed budget.

Step 3

Conduct a Free Pilot and watch how we achieve your forecasted results.

Schedule your capabilities presentation now: